25
Jun

Catabasis, at work on treatments for muscular dystrophy and high cholesterol, raised $60 million in an IPO, cashing in on investors’ continued enthusiasm for bets on biotech companies.

…read more

Source: Catabasis pulls off a $60M IPO as biotech’s Wall Street window stays open

    

0 No comments